BPG is committed to discovery and dissemination of knowledge
Gastric Cancer
©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3394-3398
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3394
Table 1 Relationship between Dnmt1 and pathological change in patients with gastric cancer (case number, %)
SubtotalDnmt1 transcription
P
Up-regulatedNormalDown-regulated
Total or subtotal28 (100.0)9 (32.14)9 (32.14)10 (35.72)
Age (yr) > 5018 (64.30)7 (38.89)4 (22.22)7 (38.89)0.30
< 5010 (35.70)2 (20.00)5 (50.00)3 (30.00)
Size of tumor >5 cm14 (50.00)4 (28.57)5 (35.71)5 (35.71)0.88
<5 cm14 (50.00)4 (28.57)5 (35.71)5 (35.71)
Borrmann II6 (21.43)2 (33.33)0 (0.00)4 (66.67)0.34
III15 (53.57)5 (33.33)6 (40.00)4 (26.67)
IV7 (25.00)2 (28.57)3 (42.86)2 (28.57)
Lymph node Positive21 (75.00)6 (28.57)8 (38.10)7 (33.33)0.49
invasion Negative7 (25.00)3 (42.86)1 (14.29)3 (42.86)


Write to the Help Desk